• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Contact Us
  • Advertise
  • About Us
  • Subscribe
  • Login

Flagstaff Business News

Northern Arizona’s premier source for business, education and health news.

  • Business
  • Columnists
  • Community Profile
  • Local News
  • Tourism
  • Calendar
  • Spotlight
You are here: Home / Local News / Gore Wins 2012 Medical Design Excellence Awards

Gore Wins 2012 Medical Design Excellence Awards

W. L. Gore & Associates (Gore)is announcing that the GORE Hybrid Vascular Graft was awarded Gold Winner in the Implant and Tissue-Replacement Products category of the 2012 Medical Design Excellence Awards (MDEA) competition. The Gore Device is an expanded polytetrafluoroethylene (ePTFE) vascular prosthesis that provides a streamlined solution for challenging dialysis access, aortic debranching, and arterial bypass procedures. The award-winning prosthesis provides a new way in for better outflow and the potential to significantly improve patient outcomes.

The MDEA winners were selected through a comprehensive review by an impartial, multidisciplinary panel of third-party jurors with expertise in biomedical engineering, clinical practice, diagnostics, human factors, industrial design, manufacturing, and medicine. Entries were evaluated on the basis of their design and engineering features, including innovative use of materials, user-related functions that improve healthcare delivery and change traditional medical attitudes or practices, features that provide enhanced benefits to the patient, and the ability of the product development team to overcome design and engineering challenges to meet its clinical objectives.

The GORE Hybrid Vascular Graft combines several trusted Gore technologies. The ePTFE vascular prosthesis has a section reinforced with nitinol that is partially constrained to allow for easy insertion and deployment into vessels that are difficult to reach or in challenging anatomical locations. It is the only combination graft that incorporates CARMEDA BioActive Surface (CBAS Surface) end-point immobilization of heparin to the luminal surface, resulting in a proven thromboresistant surface.

“This is a golden win and an example of our commitment to providing superior performance through design,” said Chuck Biggerstaff, associate with the Gore Venous Access Business. “The GORE Hybrid Vascular Graft is an innovative, versatile device that expands treatment options and improves patient outcomes.”

Share this:

  • Facebook
  • Twitter
  • LinkedIn
  • Email
  • More
  • Print
  • Reddit
  • Tumblr
  • Pinterest
  • Pocket
  • Skype

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

Footer

Advertisement

Get FBN Email

Follow FBN on Facebook

Follow FBN on Facebook
COPYRIGHT © 2021 | FLAGSTAFF BUSINESS NEWS | Powered by DRCMedia LLC
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.